×
Craig Tooman joined Silence as Chief Financial Officer in January 2021 and was appointed President, Chief Executive Officer and Executive Director in February ...
13.06.2024 г. · Craig Tooman is very proud of what Silence Therapeutics has accomplished, and not just because he's the CEO of the company.
Highly successful international executive with over twenty five years of pharmaceutical… · Experience: Silence Therapeutics plc · Education: University of ...
Craig A Tooman is President/CEO at Silence Therapeutics PLC. See Craig A Tooman's compensation, career history, education, & memberships.
Total number of appointments 1. Date of birth: October 1965. SILENCE THERAPEUTICS (LONDON) LIMITED (02757200). Company status: Active.
26.02.2024 г. · Craig Tooman describes Silence's two lead programs targeting Lp(a) and polycythemia vera, as well as how the company is trying to execute on ...
18.06.2024 г. · Discover how Craig Tooman, President and CEO, navigated the #biotech sector's post-pandemic funding challenges to strengthen Silence's ...
Craig Tooman joins the Business of Biotech to share how he applies his finance-minded leadership to steward the advance of the company's deepening pipeline of ...
Craig Allen Tooman founded Stockbourne LLC in 2011, where he worked as Principal from 2011 to 2012. Mr. Tooman also currently works at Silence Therapeutics ...